144 related articles for article (PubMed ID: 11566919)
1. Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet.
Labat C; Lacolley P; Lajemi M; de Gasparo M; Safar ME; Benetos A
Hypertension; 2001 Sep; 38(3):439-43. PubMed ID: 11566919
[TBL] [Abstract][Full Text] [Related]
2. Sodium, arterial stiffness, and cardiovascular mortality in hypertensive rats.
Mercier N; Labat C; Louis H; Cattan V; Benetos A; Safar ME; Lacolley P
Am J Hypertens; 2007 Mar; 20(3):319-25. PubMed ID: 17324746
[TBL] [Abstract][Full Text] [Related]
3. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone.
Lacolley P; Labat C; Pujol A; Delcayre C; Benetos A; Safar M
Circulation; 2002 Nov; 106(22):2848-53. PubMed ID: 12451013
[TBL] [Abstract][Full Text] [Related]
4. Effects of nitric oxide synthase inhibition and low-salt diet on blood pressure and mesenteric resistance artery remodelling in genetically hypertensive rats.
Ledingham JM; Laverty R
Clin Exp Pharmacol Physiol; 2001 Sep; 28(9):761-3. PubMed ID: 11560124
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.
Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
J Pharmacol Exp Ther; 2011 Nov; 339(2):358-66. PubMed ID: 21807884
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 2nd communication: valsartan prevents end-organ damage in spontaneously hypertensive stroke-prone rats during 1-year treatment.
Kometani M; Hayashi N; Yamamoto S; Nakao K; Inukai T
Arzneimittelforschung; 1997 May; 47(5):613-9. PubMed ID: 9205774
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind study of valsartan versus metoprolol on arterial distensibility and endothelial function in essential hypertension.
Kosch M; Levers A; Lang D; Bartels V; Rahn KH; Pavenstädt H; Hausberg M
Nephrol Dial Transplant; 2008 Jul; 23(7):2280-5. PubMed ID: 18194979
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vascular angiotensin-converting enzyme by telmisartan via the peroxisome proliferator-activated receptor gamma agonistic property in rats.
Takai S; Jin D; Kimura M; Kirimura K; Sakonjo H; Tanaka K; Miyazaki M
Hypertens Res; 2007 Dec; 30(12):1231-7. PubMed ID: 18344629
[TBL] [Abstract][Full Text] [Related]
9. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
Lassila M; Finckenberg P; Pere AK; Krogerus L; Ahonen J; Vapaatalo H; Nurminen ML
Br J Pharmacol; 2000 Jul; 130(6):1339-47. PubMed ID: 10903974
[TBL] [Abstract][Full Text] [Related]
10. Prevention of arterial structural alterations with verapamil and trandolapril and consequences for mechanical properties in spontaneously hypertensive rats.
Koffi I; Lacolley P; Kirchengaast M; Pomiès JP; Laurent S; Benetos A
Eur J Pharmacol; 1998 Nov; 361(1):51-60. PubMed ID: 9851541
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure variability, impaired autonomic function and vascular senescence in aged spontaneously hypertensive rats are ameliorated by angiotensin blockade.
Sueta D; Koibuchi N; Hasegawa Y; Toyama K; Uekawa K; Katayama T; Ma M; Nakagawa T; Waki H; Maeda M; Ogawa H; Kim-Mitsuyama S
Atherosclerosis; 2014 Sep; 236(1):101-7. PubMed ID: 25016364
[TBL] [Abstract][Full Text] [Related]
12. Enalapril and valsartan improve cyclosporine A-induced vascular dysfunction in spontaneously hypertensive rats.
Lassila M; Finckenberg P; Pere AK; Vapaatalo H; Nurminen ML
Eur J Pharmacol; 2000 Jun; 398(1):99-106. PubMed ID: 10856453
[TBL] [Abstract][Full Text] [Related]
13. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
Ledingham JM; Laverty R
Clin Exp Pharmacol Physiol; 2005; 32(1-2):76-85. PubMed ID: 15730439
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 1 receptor blocker reduces monocyte adhesion to endothelial cells in spontaneously hypertensive rats.
Ikeda F; Azuma K; Ogihara T; Toyofuku Y; Otsuka A; Mita T; Hirose T; Tanaka Y; Kawamori R; Watada H
Endocr J; 2007 Aug; 54(4):605-12. PubMed ID: 17641443
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 1 receptor blockade prevents lethal malignant hypertension: relation to kidney inflammation.
Hilgers KF; Hartner A; Porst M; Veelken R; Mann JF
Circulation; 2001 Sep; 104(12):1436-40. PubMed ID: 11560862
[TBL] [Abstract][Full Text] [Related]
17. Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats.
Takai S; Jin D; Ikeda H; Sakonjo H; Miyazaki M
Hypertens Res; 2009 Oct; 32(10):853-60. PubMed ID: 19662023
[TBL] [Abstract][Full Text] [Related]
18. Effects of valsartan and hydrochlorothiazide alone and in combination on blood pressure and heart rate in conscious-telemetered spontaneously hypertensive rats (SHR).
Webb RL; Navarrete AE; Davis S
Am J Hypertens; 1998 Jan; 11(1 Pt 1):59-65. PubMed ID: 9504451
[TBL] [Abstract][Full Text] [Related]
19. Changes in the composition of the thoracic aortic wall in spontaneously hypertensive rats treated with losartan or spironolactone.
Han WQ; Wu LY; Zhou HY; Zhang J; Che ZQ; Wu YJ; Liu JJ; Zhu DL; Gao PJ
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):583-8. PubMed ID: 19673944
[TBL] [Abstract][Full Text] [Related]
20. Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
Ke YS; Cao H; Yang T
Acta Pharmacol Sin; 2000 Nov; 21(11):1043-7. PubMed ID: 11501062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
